# Ani Pharmaceuticals Inc. (ANIP) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $883M |
| 2024 | $614M |
| 2023 | $487M |
| 2022 | $316M |
| 2021 | $216M |
| 2020 | $208M |
| 2019 | $207M |
| 2018 | $202M |
| 2017 | $177M |
| 2016 | $129M |
| 2015 | $76M |
| 2014 | $56M |
| 2013 | $30M |
| 2012 | $20M |
| 2011 | $435,160 |
| 2010 | $2M |
| 2009 | $1M |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $237M |
| 2025-09-30 | $228M |
| 2025-06-30 | $211M |
| 2025-03-31 | $197M |
| 2024-09-30 | $148M |
| 2024-06-30 | $138M |
| 2024-03-31 | $137M |
| 2023-09-30 | $132M |
| 2023-06-30 | $117M |
| 2023-03-31 | $107M |
| 2022-09-30 | $84M |
| 2022-06-30 | $74M |
| 2022-03-31 | $64M |
| 2021-09-30 | $52M |
| 2021-06-30 | $49M |
| 2021-03-31 | $55M |
| 2020-09-30 | $53M |
| 2020-06-30 | $48M |
| 2020-03-31 | $50M |
| 2019-09-30 | $51M |
| 2019-06-30 | $54M |
| 2019-03-31 | $53M |
| 2018-09-30 | $51M |
| 2018-06-30 | $47M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/ANIP/revenue)